About
Founder’s Story
Manojeet Bhattacharya is an entrepreneur, a scientist, an inventor, and a medical device technologist. He started his career as a Nuclear Astrophysicist in academia and then spent several years at government laboratories in space exploration and in nuclear energy. Since 2009 he has been developing and commercializing medical device technology for diagnostic imaging and radiation therapy, first as a Key Expert in the Molecular Imaging division of Siemens Healthineers, developing solutions for Cardiology, Oncology, and Theragnostics that are currently in clinical use, and since early 2020 as the founder of EmpNia a medical device startup. Having noticed the lack of a simple and effective motion management solution for delivering precision radiation therapy to all cancer patients, he embarked on a journey to develop and commercialize eMotus, an easy to use, universal, and cost-effective solution for respiratory motion management solution to enable precision imaging and therapy in every setting.
Leadership Team
Manojeet Bhattacharya, PhD
CEO
Manojeet Bhattacharya is a scientist, medical device technologist, and inventor with a background in nuclear astrophysics and applied nuclear physics. Since 2009, he has focused on developing and commercializing medical imaging and radiation therapy technologies, including solutions for Cardiology, Oncology, and Theragnostics currently in clinical use.
Consulting CMO
Dr. Robinson is a Professor of Radiation Oncology and Cardiology at Washington University in St. Louis. He holds several leadership roles, including Associate Director of Clinical Programs, Medical Director of Radiation Oncology Clinical Research, Chief of the Cardiothoracic and Stereotactic Body Radiotherapy services, and Co-Director of the
Center for Noninvasive Cardiac Radiotherapy. Dr. Robinson has established research interests developing and standardizing advanced radiotherapy technologies and novel drug combinations, promoting and codifying multi disciplinary care and patient-centered decision making, and developing and testing new indications for radiotherapy. He is a Principal investigator for the international randomized PACIFIC-4 trial examining SBRT with or without immunotherapy for early stage lung cancer, a multi-center NIH R01 funded trial examining patient-centered decision making for early stage lung cancer, and an NIH U54 center grant exploring tumor microenvironment effects after radiotherapy. He is also a key developer of the recently opened pivotal randomized Varian sponsored RADIATE-VT trial comparing cardiac radioablation to repeat catheter ablation for patients with high risk refractory ventricular tachycardia.
Consulting CFO
Leota Pearson, CPA, is a Contract CFO with more than 35 years of experience working with life science companies that span all stages of growth. She has a proven track record of strong leadership and results in fast-paced, demanding and rapidly-changing environments. Leota has worked as a CFO in public and private medical device companies including Orthomet, Endocardial Solutions and Celleration. She has had direct report responsibility for accounting, HR and IT. In 2010, she started a consulting practice focused on companies in the life science area where she oversees financial reporting, budgeting, forecasting, internal control and closing of equity and debt financings as well as HR.
Leota is a member of the Minnesota CPA Society having served on their board of directors and Financial Executive International where she served on the national board and as the president of its Twin Cities chapter. She was named Consulting CFO of the year in 2017 by the Minneapolis/St. Paul Business Journal. Leota holds an undergraduate degree from The University of North Dakota and a MBA from the University of Minnesota.
COO
With over 30 years of experience in the medical device industry, Evan brings deep Operational, Regulatory, Product Development and Financial experience to the company. Evan earned his BA in Business from Hamline University and his MSMS from the University of St. Thomas School of Engineering. He is co-inventor on 5 medical device patents.
CSO
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Ryan Denney
Advisor
Commercial leader with proven track record in the medical device industry.
Geoff Shipsides, JD
Advisor
Highly experienced attorney and business executive.
Advisor
Neuroradiology thought leader, innovator, and accomplished business executive.
Scientific Advisory Board
Philip Gilbo, MD
Radiation Oncologist, Nuvance Health
Daphne Haas-Kogan, MD
Department Chair of Radiation Oncology, Massachusetts General Hospital
Nicolas Kuritzky, MD
Chief of Radiation Oncology, Mount Sinai Miami
Percy Lee, MD
Radiation Oncologist and Vice Chair of Clinical Research, Department of Radiation Oncology, City of Hope
Pamela Samson, MD
Professor of Radiation Oncology, Washington University
Philip Gilbo, MD
Radiation Oncologist, Nuvance Health
Daphne Haas-Kogan, MD
Department Chair of Radiation Oncology, Massachusetts General Hospital
Nicolas Kuritzky, MD
Chief of Radiation Oncology, Mount Sinai Miami
Percy Lee, MD
Radiation Oncologist and Vice Chair of Clinical Research, Department of Radiation Oncology, City of Hope
Jay Shelton, MD
Radiation Oncologist, Emory Healthcare
Kevin Stephans, MD
Radiation Oncologist, Cleveland Clinic
Sarah Jo Stephens, MD
Radiation Oncologist, Duke Health
Ashley Weiner, MD, PHD
Radiation Oncologist, UNC Health
Pamela Samson, MD
Professor of Radiation Oncology, Washington University
Jay Shelton, MD
Radiation Oncologist, Emory Healthcare
Kevin Stephans, MD
Radiation Oncologist, Cleveland Clinic
Sarah Jo Stephens, MD
Radiation Oncologist, Duke Health
Ashley Weiner, MD, PHD
Radiation Oncologist, UNC Health